Kalin Katherine Bach
SEC insider (Form 3/4/5 filer). CIK 0001832671. Director at SELLAS Life Sciences Group, Inc. (SLS). 4 reported Form 4/5 transactions since Sep 2024; latest on Jan 7, 2026. Located in NEW YORK, NY.
Companies Kalin Katherine Bach has filed insider reports for
- SELLAS Life Sciences Group, Inc. (SLS): Director
Kalin Katherine Bach
CIK: 0001832671
Transaction Breakdown
Open Market Buys (P)2 (50.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
SLS
SELLAS Life Sciences Group, Inc.
Director
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jan 7, 2026SLS
SELLAS Life Sciences Group, Inc.
AwardDirect50K shares- - Nov 19, 2025SLS
SELLAS Life Sciences Group, Inc.
PurchaseDirect63.4K shares at avg. $1.59$101K - May 22, 2025SLS
SELLAS Life Sciences Group, Inc.
PurchaseDirect20K shares at avg. $1.80$36K - Jan 10, 2025SLS
SELLAS Life Sciences Group, Inc.
AwardDirect12.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 7, 2026 | SLS SELLAS Life Sciences Group, Inc. | Award | 50,000 | - | $0 | Direct |
| Nov 19, 2025 | SLS SELLAS Life Sciences Group, Inc. | Purchase | 63,400 | $1.59 | $100,806 | Direct |
| May 22, 2025 | SLS SELLAS Life Sciences Group, Inc. | Purchase | 20,000 | $1.80 | $36,000 | Direct |
| Jan 10, 2025 | SLS SELLAS Life Sciences Group, Inc. | Award | 12,500 | - | $0 | Direct |
1-4 of 4 transactions